Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
03 03 2021
Historique:
pubmed: 31 12 2020
medline: 20 2 2021
entrez: 30 12 2020
Statut: ppublish

Résumé

Older age and cardiovascular comorbidities are well-known risk factors for all-cause mortality in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 principal determinants of arterial stiffness (AS). This study aimed to estimate AS in patients with COVID-19 requiring hospitalization and analyze its association with all-cause in-hospital mortality. This observational, retrospective, multicenter cohort study analyzed 12 170 patients admitted to 150 Spanish centers included in the SEMI-COVID-19 Network. We compared AS, defined as pulse pressure ≥60 mm Hg, and clinical characteristics between survivors and nonsurvivors. Mean age was 67.5 (±16.1) years and 42.5% were women. Overall, 2606 (21.4%) subjects died. Admission systolic blood pressure (BP) <120 and ≥140 mm Hg was a predictor of higher all-cause mortality (23.5% and 22.8%, respectively,

Identifiants

pubmed: 33377393
doi: 10.1161/HYPERTENSIONAHA.120.16563
pmc: PMC7884247
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

856-867

Références

Hypertension. 2011 Nov;58(5):825-32
pubmed: 21911710
Trends Endocrinol Metab. 2014 Feb;25(2):72-9
pubmed: 24365513
Rev Clin Esp. 2020 Nov;220(8):480-494
pubmed: 33994573
Artery Res. 2020;27(2):59
pubmed: 35414837
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Hypertension. 2009 Jul;54(1):3-10
pubmed: 19487587
Pharmacol Res. 2020 Jun;156:104832
pubmed: 32304747
Hypertension. 2020 Aug;76(2):366-372
pubmed: 32564693
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
J Pathol. 2007 Jan;211(2):144-56
pubmed: 17200946
Eur Heart J. 2010 Apr;31(7):883-91
pubmed: 20034972
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
Hypertension. 2020 Feb;75(2):477-482
pubmed: 31884854
Am J Cardiol. 2001 Jun 1;87(11):1278-81
pubmed: 11377354
Lancet. 2016 Oct 29;388(10056):2142-2152
pubmed: 27590221
Hypertension. 2020 Feb;75(2):297-298
pubmed: 31884858
Lancet. 2016 Nov 26;388(10060):2665-2712
pubmed: 27671667
Circulation. 2003 Nov 11;108(19):2317-22
pubmed: 14568895
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Hypertension. 2009 Dec;54(6):1213-5
pubmed: 19884560
JAMA. 2002 May 22-29;287(20):2677-83
pubmed: 12020303
Inflamm Res. 2020 Sep;69(9):825-839
pubmed: 32529477
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
J Hypertens. 2012 Mar;30(3):445-8
pubmed: 22278144
Circulation. 2009 Jan 20;119(2):243-50
pubmed: 19118251
Blood Press. 2018 Dec;27(6):314-340
pubmed: 30380928
Lancet. 2017 Jun 3;389(10085):2226-2237
pubmed: 28390695
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32430432
Nat Rev Immunol. 2019 Aug;19(8):517-532
pubmed: 30992524
Eur Heart J. 2007 Jun;28(12):1462-536
pubmed: 17562668
JAMA. 2012 Sep 5;308(9):875-81
pubmed: 22948697
J Am Soc Nephrol. 2016 Mar;27(3):677-86
pubmed: 26319245
N Engl J Med. 2019 Feb 21;380(8):752-762
pubmed: 30415610
J Gen Intern Med. 2021 Jan;36(1):17-26
pubmed: 32607928
J Hypertens. 2014 Dec;32(12):2285-95
pubmed: 25255397
J Clin Med. 2020 Sep 28;9(10):
pubmed: 32998337
Hypertension. 2007 Aug;50(2):299-305
pubmed: 17606861
PLoS One. 2020 Jun 17;15(6):e0234764
pubmed: 32555674

Auteurs

Enrique Rodilla (E)

From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).
Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.).

Maria Dolores López-Carmona (MD)

Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.).

Xavi Cortes (X)

From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).
Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.).

Lidia Cobos-Palacios (L)

Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.).

Sergio Canales (S)

From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).
Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.).

Maria Carmen Sáez (MC)

From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).
Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.).

Samara Campos Escudero (S)

Internal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain (S.C.E.).

Manuel Rubio-Rivas (M)

Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat (Barcelona), Spain (M.R.-R.).

Jesus Díez Manglano (J)

Internal Medicine Department, Royo Villanova Hospital, Zaragoza, Spain (J.D.M.).

Santiago J Freire Castro (SJ)

Internal Medicine Department, A Coruña University Hospital, Spain (S.J.F.C.).

Nuria Vázquez Piqueras (N)

Internal Medicine Department, Consorci Sanitari Integral, Moisès Broggi Hospital Sant Joan Despí (Barcelona), Spain (N.V.P.).

Elisabeth Mateo Sanchis (E)

Internal Medicine Department, Dr. Peset University Hospital, Valencia, Spain (E.M.S.).

Paula Maria Pesqueira Fontan (PM)

Internal Medicine Department, Santiago Clinical Hospital, Santiago de Compostela (A Coruña), Spain (P.M.P.F.).

Jeffrey Oskar Magallanes Gamboa (JO)

Internal Medicine Department, Nuestra Señora del Prado Hospital, Talavera de la Reina (Toledo), Spain (J.O.M.G.).

Andrés González García (A)

Internal Medicine Department, Ramón y Cajal University Hospital, Madrid, Spain (A.G.G.).
Internal Medicine Department, Defensa General Hospital, Zaragoza, Spain (A.G.G.).

Victor Madrid Romero (V)

Internal Medicine Department, Zamora Hospital Complex, Spain (V.M.R.).

Lara Tamargo Chamorro (L)

Internal Medicine Department, Cabueñes Hospital, Gijón (Asturias), Spain (L.T.C.).

Julio González Moraleja (J)

Internal Medicine Department, Virgen de la Salud Hospital, Toledo, Spain (J.G.M.).

Javier Villanueva Martínez (J)

Internal Medicine Department, Infanta Cristina University Hospital, Parla (Madrid), Spain (J.V.M.).

Amara González Noya (A)

Internal Medicine Department, Ourense University Hospital Complex, Ourense, Spain (A.G.N.).

Ana Suárez-Lombraña (A)

Internal Medicine Department, Platón Hospital, Barcelona, Spain (A.S.-L.).

Anyuli Gracia Gutiérrez (A)

Internal Medicine Department, Ramón y Cajal University Hospital, Madrid, Spain (A.G.G.).
Internal Medicine Department, Defensa General Hospital, Zaragoza, Spain (A.G.G.).

Manuel Lorenzo López Reboiro (ML)

Internal Medicine Department, Monforte de Lemos Hospital, Spain (M.L.L.R.).

José Manuel Ramos Rincón (JM)

Department of Clinical Medicine, Miguel Hernandez University of Elche, Alicante, Spain (J.M.R.R.).

Ricardo Gómez Huelgas (R)

Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH